Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Rong

Showing results (461-470 of 483) with videos related to

Pageof 49
Sort By:
Blood|March 29, 2013
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trialHong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2023
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized TrialLi Xiang, Jin-Feng Rong, Xin-Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancerLiang Zeng, Fan Tong, Xingxiang Xu, et al.
Transplantation and Cellular Therapy|October 22, 2022
Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patientsRui-Xin Deng, Xiao-Lu Zhu, Ao-Bei Zhang, et al.
American Journal of Hematology|September 29, 2023
A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Clinical Transplantation|July 21, 2025
Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti-Thymocyte GlobulinFeng-Mei Zheng, Jun Kong, Jing-Zhi Wang, et al.
Cancer Letters|August 31, 2024
Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Transplantation and Cellular Therapy|December 27, 2023
Prognostic Factors and Outcomes in Patients With Septic Shock After Allogeneic Hematopoietic Stem Cell TransplantationQiu-Sha Huang, Tian-Xiao Han, Hai-Xia Fu, et al.
Transplantation and Cellular Therapy|July 6, 2021
A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell TransplantationLe-Qing Cao, Jing-Rui Zhou, Xiao-Hui Zhang, et al.
Pageof 49

Showing results (461-470 of 483) with videos related to

Sort By:
Pageof 49
Blood|March 29, 2013
MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trialHong-Hu Zhu, Xiao-Hui Zhang, Ya-Zhen Qin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2023
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized TrialLi Xiang, Jin-Feng Rong, Xin-Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2018
Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete RemissionMeng Lv, Yu Wang, Ying-Jun Chang, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancerLiang Zeng, Fan Tong, Xingxiang Xu, et al.
Transplantation and Cellular Therapy|October 22, 2022
Machine learning algorithm as a prognostic tool for venous thromboembolism in allogeneic transplant patientsRui-Xin Deng, Xiao-Lu Zhu, Ao-Bei Zhang, et al.
American Journal of Hematology|September 29, 2023
A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Clinical Transplantation|July 21, 2025
Incidence, Risk Factors, and Impact on Transplant Outcomes of Cytokine Release Syndrome After Infusion of Haploidentical Stem Cells With Anti-Thymocyte GlobulinFeng-Mei Zheng, Jun Kong, Jing-Zhi Wang, et al.
Cancer Letters|August 31, 2024
Clinical characteristics and risk stratification for late-onset herpes zoster following allogeneic hematopoietic stem cell transplantationCheng-Jie Feng, Peng Zhao, Hai-Xia Fu, et al.
Transplantation and Cellular Therapy|December 27, 2023
Prognostic Factors and Outcomes in Patients With Septic Shock After Allogeneic Hematopoietic Stem Cell TransplantationQiu-Sha Huang, Tian-Xiao Han, Hai-Xia Fu, et al.
Transplantation and Cellular Therapy|July 6, 2021
A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell TransplantationLe-Qing Cao, Jing-Rui Zhou, Xiao-Hui Zhang, et al.
Pageof 49